Skip to main content

Table 1 Clinical anti-viral treatment features of H7N9 patients in Guangdong province, China

From: Efficacy of delayed treatment of China-made Peramivir with repeated intravenous injections in a mouse influenza model: from clinical experience to basal experiment

Patient Time (days) after onset of symptoms when anti-viral drugs were administered Anti-viral drug used Clinical outcome
1 22 Oseltamivir Survival
2 8
3 8
4 7 Oseltamivir, China-made Peramivir Survival
5 13 Oseltamivir, Zanamivir, China-made Peramivir Death
6 9 Oseltamivir, Zanamivir Survival
7 11
  1. *Some of these data were published by our research team, Zifeng Yang et al. [21]